Loading
If this is the first time anyone has visited this substance, we may be fetching live data from TGA Product Information, PBS, and state framework sources — that can take up to a minute. Cached substances load in a second or two.
Curated subset. The full adverse-effect list is in the TGA Product Information; click any citation above to open it.
“The action of lauromacrogol 400 in this technique is considered to be that of irritation to the intima of the vein wall (disruption of the vascular endothelium causing a thrombus formation that occludes the blood vessel reducing it to a fibrotic cord).”
“There was a rapid disposition phase with a half-life of 19 minutes, and an elimination phase with a half-life of 4 hours.”
Working under the parallel aged-care framework? Aged-care equivalent →